Health

EU backs AstraZeneca drug for Covid treatment

September 16, 2022 | 01:41 p.m EDT

London: AstraZeneca's Evusheld drug has been recommended for marketing in the European Union to treat patients at risk of death from Covid, the British pharmaceutical group said Friday.

The EU's drug watchdog had already approved Evusheld for the prevention of coronavirus in such patients.

"Evusheld long-acting antibody combination" has been "recommended for approval in the EU for the treatment of Covid-19", AstraZeneca said in a statement.

Its use via injection is recommended for adults and children aged 12 and above "who are at increased risk of progressing to severe Covid‑19", it added.

The European Medicines Agency's latest Evusheld recommendation followed trials showing "significant protection against progression to severe Covid-19 or death".

September 16, 2022 01:41 PM

Opinion

Welcome Modi

Opinion

India-Kuwait relations: A long history and ongoing partnership

Syria’s path forward

Everyone I met expressed heartfelt prayers for the Syrian people, hoping they will succeed in rebuilding their country. Perhaps this great people will learn from the experiences of other nations — from those who failed to unite their ranks and tho...

You’re invited to a party

Nermin Alhouti The play You’re Invited to a Party was crowned with the best overall production at the 24th Kuwait Theater Festival. While I won’t delve into an analysis of the play’s elements, it’s clear that its distinct and cohesive theatr...